Clinical features and drug resistance in patients with acute Campylobacter jejuni-induced enteritis

CHEN Jie,SUN Xin-ting,ZENG Zheng,WANG Gui-qiang,YU Yan-yan

DOI: https://doi.org/10.3969/j.issn.1007-8134.2011.01.007

2011-01-01

Abstract:Objective To investigate clinical features and drug resistance in patients with acute Campylobacter jejuni-induced enteritis and to provide evidence for epidemiological study,clinical diagnosis and rational drug use of the disease in Beijing.Methods Clinical features were analyzed retrospectively in 142 patients with acute Campylobacter jejuni-induced enteritis treated in our hospital in the summer or autumn from 2005 to 2009.Antimicrobial susceptibility testing was performed by Kirby-Bauer disk diffusion method.Results Campylobacter jejuni-induced enteritis developed the most frequently in June and in the population aged 20-29.Diarrhea manifested itself mainly as watery stool or mucous stool(97.2%),and seldomly as bloody purulent stool or mucopurulent bloody stool.Other clinical manifestations were abdominal pain(72.5%),fever(64.8%),nausea(21.1%),tenesmus(18.3%) and vomiting(10.6%).Antimicrobial susceptibility testing was performed on 60 strains of Campylobacter jejuni and 6.7% of the isolates were resistant to erythromycin,11.7% to gentamicin,1.7% to azithromycin,100.0% to cefoperazone and 60.0% to levofloxacin.No patients died and no ones were combined with Guillain-Barre syndrome and reactive arthritis.Conclusions Acute Campylobacter jejuni-induced enteritis has diverse and complicated clinical manifestations and drug resistance,and runs a benign clinical course in the majority of the patients.The patients are lowly susceptible to cefoperazone and when antibiotics are necessary,erythromycin can be chosen firstly.